J
Jeremy D. Walston
Researcher at Johns Hopkins University
Publications - 337
Citations - 48109
Jeremy D. Walston is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 80, co-authored 302 publications receiving 39548 citations. Previous affiliations of Jeremy D. Walston include Johns Hopkins University School of Medicine & University of Baltimore.
Papers
More filters
Journal ArticleDOI
Knockout of Angiotensin AT2 receptors accelerates healing but impairs quality.
Mahya Faghih,Sayed Mohammad Hosseini,Barbara S. Smith,Amir Mehdi Ansari,Frank Lay,Ali Karim Ahmed,Tedashi Inagami,Guy P. Marti,John W. Harmon,Jeremy D. Walston,Peter M. Abadir +10 more
TL;DR: The results suggest that in the absence of AT2R, wound healing rate is accelerated, but yielded worse skin quality, and elucidating the contribution of both of the angiotensin receptors may help fine tune future intervention aimed at wound repair in older individuals.
Journal ArticleDOI
Aged interleukin-10tm1Cgn chronically inflamed mice have substantially reduced fat mass, metabolic rate, and adipokines
Reyhan Westbrook,Huan Le Yang,Jackie M. Langdon,Cindy N. Roy,Jin A. Kim,Parichoy Pal Choudhury,Qian Li Xue,Andrea Di Francesco,Rafa de Cabo,Jeremy D. Walston +9 more
TL;DR: Fat mass is decreased with age in IL 10tm mice compared to controls and NMR based body composition analysis and dissection weights suggest that frailty observed in this mouse model of chronic inflammation may in part be driven by alterations in fat mass, hormone secretion and energy metabolism.
Journal ArticleDOI
Interferon-γ Potentiates α-Synuclein-induced Neurotoxicity Linked to Toll-like Receptors 2 and 3 and Tumor Necrosis Factor-α in Murine Astrocytes.
TL;DR: Interferon (IFN)-γ potentiates α-synuclein (A53T or wild-type)-induced innate immunity, involving expressions of TLR2, TLR3, NF-κB, and TNF-α, other than IL-1β, suggesting that involvement of IFN-γ in α- synuclein's innate immunity may be required for initiation and maintenance of glial activation, a novel neurotoxic mechanism underlying pathogenesis of neurodegenerative
Journal ArticleDOI
Models and Studies of Aging: Executive Summary of a Report from the U13 Conference Series
Arti Hurria,Chris Carpenter,Frances McFarland,Nancy E. Lundebjerg,Rafael de Cabo,Luigi Ferrucci,Stephanie A. Studenski,Nir Barzilai,Josephine P. Briggs,Joachim H. Ix,Dalane W. Kitzman,George A. Kuchel,Nicolas Musi,John C. Newman,John C. Newman,Thomas A. Rando,Alexander K. Smith,Jeremy D. Walston,James L. Kirkland,Raymond Yung +19 more
TL;DR: This article provides a summary of the full conference report, Models and Studies of Aging: Report from the U13 Conference Series, and summarizes key take‐home messages that were designed to support GEMSSTAR awardees in developing their research careers focused on aging research.
Journal ArticleDOI
A prospective randomized wait list control trial of intravenous iron sucrose in older adults with unexplained anemia and serum ferritin 20–200 ng/mL
Elizabeth A. Price,Andrew S. Artz,Huiman X. Barnhart,Shelly Sapp,Gordon J. Chelune,William B. Ershler,Jeremy D. Walston,Victor R. Gordeuk,Nathan A. Berger,David B. Reuben,Josef T. Prchal,Sunil V. Rao,Cindy N. Roy,Mark A. Supiano,Stanley L. Schrier,Harvey J. Cohen +15 more
TL;DR: A subgroup of adults with UAE may respond to intravenous iron, and this study carried out a randomized, wait list control trial in outpatients with UAE and serum ferritin levels between 20 and 200 ng/mL.